ASCO 2024: DDR Post-Conference Report

Our Beacon DDR experts have screened the abstracts presented at the 2024 ASCO Annual Meeting, held in Chicago from the 31st May to the 4th June, and identified 92 abstracts (81 clinical and 11 preclinical) associated with records on Beacon DDR. These have been analyzed and listed in our Post-Conference Report.

ASCO 2024: DDR Abstract Highlights

This post-conference report sample provides a guide to the DDR-relevant abstracts presented at the 2024 ASCO Conference, offering you a list of each abstract with information on developmental phase, target, asset, abstract summaries and more, as well as links to each. Download your free sample today.

You May Also Be Interested In…

Learn More About DDR

What is Beacon DDR?
  • The Most Comprehensive Way to Search the DDR Drug Development Landscape: Unique search ontologies based on DDR drug and trial characteristics
  • Market Leading Approach to DDR Preclinical & Clinical Data Curation: Manual curation of key DDR research and development data points by DDR research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search DDR company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon DDR

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search